PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-13.69%
Negative net income growth while ORCL stands at 0.47%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-0.48%
Both reduce yoy D&A, with ORCL at -2.61%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-7.95%
Negative yoy deferred tax while ORCL stands at 5.66%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
1.86%
Less SBC growth vs. ORCL's 10.44%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
92.76%
Well above ORCL's 80.76% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
151.30%
AR growth well above ORCL's 102.37%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-131.49%
Both reduce yoy inventory, with ORCL at -12.50%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-218.94%
Both negative yoy AP, with ORCL at -142.73%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
15.42%
Lower 'other working capital' growth vs. ORCL's 86.93%. David Dodd would see fewer unexpected short-term demands on cash.
3.32%
Lower 'other non-cash' growth vs. ORCL's 36.92%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
128.85%
Operating cash flow growth at 75-90% of ORCL's 164.14%. Bill Ackman would recommend further refinements to match competitor’s CFO gains.
31.18%
Some CapEx rise while ORCL is negative at -16.67%. John Neff would see competitor possibly building capacity while we hold back expansions.
-12.95%
Both yoy lines negative, with ORCL at -203.69%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-62.45%
Negative yoy purchasing while ORCL stands at 30.14%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
32.86%
1.25-1.5x ORCL's 23.05%. Bruce Berkowitz sees a sizable advantage unless competitor’s portfolio yields future gains.
-72.46%
We reduce yoy other investing while ORCL is 184.20%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-317.95%
We reduce yoy invests while ORCL stands at 122.31%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
48.98%
Debt repayment growth of 48.98% while ORCL is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
20.51%
Lower share issuance yoy vs. ORCL's 57.08%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
12.68%
Buyback growth below 50% of ORCL's 27.99%. Michael Burry suspects fewer capital returns to shareholders vs. competitor, unless expansions hold higher ROI.